SQUAMOUS CELL CARCINOMA OF THE VULVA

This adverse event was reported 100 times

These drugs are most commonly taken by patients reporting SQUAMOUS CELL CARCINOMA OF THE VULVA:

# Drug Count
0 TACROLIMUS 10
1 TACROLIMUS EXTENDED-RELEASE CAPSULES 10
2 TACROLIMUS OINTMENT 0.1% 10
3 CARBOPLATIN 7
4 BEVACIZUMAB 6
5 PACLITAXEL 6
6 METHOTREXATE SODIUM 5
7 ADALIMUMAB 4
8 ALPRAZOLAM 4
9 CITALOPRAM 4
See all common drugs associated with SQUAMOUS CELL CARCINOMA OF THE VULVA

SQUAMOUS CELL CARCINOMA OF THE VULVA is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 HALOBETASOL PROPIONATE 2 0.0015
1 ESTRADIOL VALERATE 1 0.0013
2 ACITRETIN 2 0.0004
3 OSPEMIFENE 1 0.0004
4 CEFUROXIME AXETIL 1 0.0003
5 PHENAZOPYRIDINE 1 0.0003
6 TRIAZOLAM 1 0.0002
7 HYDROXOCOBALAMIN 1 0.0002
8 TEDUGLUTIDE 2 0.0001
9 BENDAMUSTINE HCL 2 0.0001
See all drugs enriched for association with SQUAMOUS CELL CARCINOMA OF THE VULVA